75

10 May 2019

Acacia Pharma’s BARHEMSYS® Significantly Improves Post-operative Nausea & Vomiting (PONV) in Rescue Treatment of Ambulatory Patients

American Society of Peri-Anesthesia Nurses (ASPAN)

Nashville, TN
5-9 May 2019

07 May 2019

Notice of Annual General Meeting

03 May 2019

Acacia Pharma Receives Complete Response Letter from FDA for BARHEMSYS®

25 April 2019

Positive Phase 3 BARHEMSYS® Rescue Treatment Data to be Presented at the Annual Congress of Enhanced Recovery and Perioperative Medicine

Regional Anesthesia and Pain Medicine (ASRA)

Las Vegas, NV
11-13 April 2019

27 February 2019

Results for the year ended 31 December 2018

28 January 2019

Editorial in Anesthesiology on Positive Data for BARHEMSYS™ PONV Rescue Treatment

22 January 2019

Supportive Cardiac Safety Data for BARHEMSYS™

JP Morgan Healthcare Conference, San Francisco

January 7-10

12 December 2018

Positive Clinical Results for APD403 in CINV Published in Supportive Care in Cancer

07 December 2018

New BARHEMSYS™ PDUFA date confirmed for 5 May 2019

21 November 2018

Positive BARHEMSYS™ Rescue Treatment Data Published in Anesthesiology

Jefferies London Healthcare Conference, London

November 14-15

06 November 2018

Acacia Pharma Resubmits BARHEMSYS™ New Drug Application

06 November 2018

Unaudited Results for the nine months to 30 September 2018

15 October 2018

Further update on FDA regulatory review of BARHEMSYS™ 

08 October 2018

Update on FDA regulatory review of BARHEMSYS™

Health Connect Partners (HCP), Los Angeles, CA

October 1-3

Future Pharma, Boston, MA

September 26-28

Integrated Delivery Network Summit and Reverse Expo (IDN), Phoenix, AZ

September 17-19

14 September 2018

Positive BARHEMSYS™ Phase 3 Treatment Data Published in Anesthesia & Analgesia

07 September 2018

Interim Results for the First Half Year 2018

SG2 Executive Summit, Chicago, IL

July 23-25

09 July 2018

Operating Update for the First Half 2018